Bio-Techne (TECH) Tops Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Bio-Techne Releases Third Quarter Fiscal 2019 Results
April 30, 2019 6:30 AM EDTMINNEAPOLIS, April 30, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2019.
Third Quarter FY2019 Snapshot
Third quarter organic growth of 14% (13% reported) with revenue of $184.9 million. GAAP EPS was $1.15 vs. $0.52 one year ago. Delivered adjusted earnings per share (EPS) of $1.21, consistent with the prior year despite foreign currency exchange headwinds negatively impacting results by $0.10 or 8% in the third quarter. Excellent commercial execution in all major regions, with North America, Europe, and China all achieving double digit organic... More